EUVIMEDEUVIMED entdecken
Open Access

Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapy

Junedh M Amrute iD, In-Hyuk Jung iD, Tracy Yamawaki iD, Wen-Ling Lin iD, Andrea Bredemeyer iD, Johanna Diekmann iD, Sikander Hayat iD, Xianglong Zhang, Devin L Wakefield iD, Xin Luo iD, Sidrah Maryam, Gyu Seong Heo iD und 27 weitere

Science · 02.04.2026 · 392 (6793)

DOI: 10.1126/science.adx1736 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 02.04.2026. Verfasst von Junedh M Amrute und 38 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cardiovascular Research, Division of Cardiology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAMS NIH HHS, NIBIB NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular smooth muscle cell (VSMC) diversification drives atherosclerotic coronary artery disease (CAD), but the mechanisms governing these cell state transitions remain unclear. We applied multiomic single-cell profiling, epitope mapping, and spatial transcriptomics across 27 human coronary arteries, identifying fibroblast activation protein (FAP) as a marker of modulated VSMCs. Lineage tracing in mice indicated that FAP + cells originate from Myh11 + VSMCs, and FAP positron emission tomography imaging in CAD patients showed plaque uptake. FAP + cell states resided in the macrophage-rich neo-intima. Therapeutically, we developed an anti-FAP bispecific T cell engager, which reduced plaque burden and remodeled the stromal–immune microenvironment through T cell clonal expansion. Our study delivers a single-cell and spatial atlas of human CAD, establishes FAP as a marker of modulated VSMCs, and highlights immunotherapy for lipid-independent targets.

Autor:innen und Institutionen

  • Center for Cardiovascular Research, Division of Cardiology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
  • Amgen, 750 Gateway Blvd, South San Francisco, CA, USA.
  • Cardiovascular Metabolic Disease Translational Research Programme, National University Health System, Centre for Translational Medicine, 14 Medical Drive, Singapore, Singapore.
  • Institute of Molecular and Cell Biology, 61 Biopolis Drive, Singapore, Singapore.
  • These authors contributed equally to this work.
  • Amgen R&D Postdoctoral Fellows Program, South San Francisco, CA, USA.

ORCID-Profile: Junedh M Amrute, In-Hyuk Jung, Tracy Yamawaki, Wen-Ling Lin, Andrea Bredemeyer, Johanna Diekmann, Sikander Hayat, Devin L Wakefield, Xin Luo, Gyu Seong Heo, Steven Yang, Chang Jie Mick Lee, Chen Wang, Caroline Chou, Christoph Kuppe, Kevin D Cook, Vishnu Chintalgattu, Danielle Pruitt, Jose Barreda, Nathan O Stitziel, Paul Cheng, Yongjian Liu, Rafael Kramann, Daniel Kreisel, Roger S-Y Foo, Ingrid C Rulifson, Scott Martin, Melissa Thomas, Thomas Quertermous, Frank M Bengel, Chi-Ming Li, Kory J Lavine

Förderung

  • NHLBI NIH HHS
  • NIAMS NIH HHS
  • NIBIB NIH HHS
  • NCI NIH HHS
  • National Institutes of Health
  • National Center for Research Resources
  • National Cancer Institute
  • American Heart Association

Zitieren

APA

Amrute, J. M., Jung, I. H., Yamawaki, T., Lin, W. L., Bredemeyer, A., Diekmann, J., Hayat, S., Zhang, X., Wakefield, D. L., Luo, X., Maryam, S., Heo, G. S., Yang, S., Lee, C. J. M., Wang, C., Chou, C., Kuppe, C., Cook, K. D., Kovacs, A., …, & Lavine, K. J. (2026). Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapy. Science, 392(6793). https://doi.org/10.1126/science.adx1736

Vancouver

Amrute JM, Jung IH, Yamawaki T, Lin WL, Bredemeyer A, Diekmann J, et al. Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapy. Science. 2026;392(6793). doi:10.1126/science.adx1736

BibTeX
@article{Amrute2026,
  author = {Amrute, Junedh M and Jung, In-Hyuk and Yamawaki, Tracy and Lin, Wen-Ling and Bredemeyer, Andrea and Diekmann, Johanna and Hayat, Sikander and Zhang, Xianglong and Wakefield, Devin L and Luo, Xin and Maryam, Sidrah and Heo, Gyu Seong and Yang, Steven and Lee, Chang Jie Mick and Wang, Chen and Chou, Caroline and Kuppe, Christoph and Cook, Kevin D and Kovacs, Atilla and Chintalgattu, Vishnu and Pruitt, Danielle and Barreda, Jose and Stitziel, Nathan O and Cheng, Paul and Liu, Yongjian and Kramann, Rafael and Kreisel, Daniel and Foo, Roger S-Y and Rulifson, Ingrid C and Martin, Scott and Grunert, David and Thomas, Melissa and Cui, Jixin and Quertermous, Thomas and Bengel, Frank M and Jackson, Simon and Li, Chi-Ming and Ason, Brandon and Lavine, Kory J},
  title = {Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapy},
  journal = {Science},
  year = {2026},
  volume = {392},
  number = {6793},
  doi = {10.1126/science.adx1736}
}
Kostenlos starten →